Evidence map›Paper›PMID 31123503›Full record

ArticleGut pathogens2019

Cytokines derived from innate lymphoid cells assist

Xiao Han, Tianren Huang, Junqing Han

Open access · goldAbstract read
In one paragraph

Article in Gut pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. A genetic variant ofJournal of clinical microbiology · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Innate lymphoid cells and cancer.Nature immunology · 2022
    Review
  13. Review
  14. The Deletion of IL-17A EnhancesJournal of inflammation research · 2022
    Article
  15. Review
  16. Review
  17. Frontiers in microbiology · 2021
    Article
  18. The Interaction Between the Microbiome and Tumors.Frontiers in cellular and infection microbiology · 2021
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Xiao Han1Department of Experiment, Tumor Hospital Affiliated to Guangxi Medical University, 71# Hedi Road, Nanning, 530021 China.
Tianren Huang1Department of Experiment, Tumor Hospital Affiliated to Guangxi Medical University, 71# Hedi Road, Nanning, 530021 China.
Junqing Han2Department of Tumor Research and Therapy Center, Shandong Provincial Hospital Affiliated to Shandong University, 324# Jingwu Road, Jinan, 250021 China.
Tumor Hospital of Guangxi Medical University · CNShandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently, intestinal microbiome has been involved in hepatic diseases due to the immunologic and metabolic communication between liver and intestine. Initiation of hepatocellular carcinoma (HCC) frequently attributes to conspiracy between immune cells and infectious carcinogens. Here, the hypothesis that the tumorigenesis of HCC with HBV infection will be aggravated by specific intestinal bacteria was verified in viral transgenic mouse models.

methodsComparative 16S rRNA sequencing was adopted to observe the intestinal enrichment of

resultsWe found that

conclusions

Indexed as

Helicobacter hepaticusHepatitis B virusHepatocellular carcinomaIFN-γ/p-STAT1 axisInnate lymphoid cells

Identifiers

PMID31123503
PMCPMC6521485
OpenAlexW2947213031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.